1. Sorbonne Université, INSERM, CIC-1901 Paris-Est, CLIP² Galilée, UNICO-GRECO Cardio-oncology Program, and Department of Pharmacology, Pitié-Salpêtrière Hospital, Assistance Publique–Hôpitaux de Paris, F-75013 Paris, France;
2. Department of Drug Development (DITEP), Gustave Roussy, 94805 Villejuif, France
3. Sorbonne Université, INSERM, Department of Internal Medicine, Assistance Publique–Hôpitaux de Paris, F-75013 Paris, France
4. Center for Cancer Immunotherapy, INSERM U932, Institut Curie, 75248 Paris Cedex 05, France
5. Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, EA 4340, Université Paris-Saclay, 92100 Boulogne-Billancourt, France
6. Department of Medicine, Cardio-Oncology Program, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA